BioSpace News Archive

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced today its latest statistics regarding COVID-19 testing at Frankfurt and Hamburg Airports

Celsius Holdings, Inc., (Nasdaq: CELH), maker of the leading global fitness drink, CELSIUS®, today announced that chief executive officer, John Fieldly, will be presenting at the LD 500 Virtual Conference on Wednesday, September 2, 2020, at 10:40 a.m. ET / 7:40 a.m. PT.

- Evaluating etrasimod 2 mg in patients with the clinical diagnosis of moderate-to-severe alopecia areata - There are currently no FDA-approved treatments for alopecia areata [01-September-2020] SAN DIEGO , Sept. 1, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the first subject has been dosed in a Phase 2 trial evalu

- New specialty pharmaceutical company, Tavanta Therapeutics, has reorganized for long-term growth in the U.S., including the establishment of a highly experienced leadership team and global headquarters in the Philadelphia area. - Tavanta has built a product portfolio spanning early research and late clinical development of novel specialty drugs for patients with unmet medical needs including those with serious and debilitating diseases. - Tavanta takes a risk-balanced appro

Zosano Pharma Corporation, a clinical-stage biopharmaceutical company, announced the pricing of an underwritten public offering of 15,937,130 shares of its common stock for gross proceeds of approximately $20.8 million, before deducting offering expenses payable by Zosano.

TriRx Pharmaceutical Services, a global contract development and manufacturing organization (CDMO) serving the biopharmaceutical market, today announced that it has finalized an agreement with MSD Sante Animale, a division of Merck & Co., Inc., Kenilworth, N.J. , USA (NYSE:MRK), to acquire the operations and ownership of t

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced the publication of a prospective, randomized controlled trial showing clinical utility of the Prospera test.

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present at the Baird 2020 Global Healthcare Conference on Thursday, September 10 at 9:05 a.m. Eastern Time.

Perimeter Medical Imaging AI, Inc. announced today that Mr. Steve Sapot will join the company as Chief Commercial Officer, effective immediately, reporting to Mr. Jeremy Sobotta, President and CFO.

In response to its rapid growth and expansion, AmeriLife Group, LLC (“AmeriLife”), the national leader in marketing and distributing life, health and retirement solutions, today announces Tim Calvert as the company’s Chief Operating Officer.